It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pelargonium graveolens L'Hér is an important species of genus Pelargonium with an economic value. The unique rose scent of its oil is used in perfume and cosmetic industry. The oil is characterized by the presence of citronellol, geraniol and rose oxide. Fresh aerial parts of P. graveolens at GC–MS analysis of four seasons revealed that autumn constituted the highest yield of the oil. For the first time, optimization of the yield of extracted oil of P. graveolens was performed employing 3-level Box-Behnken design using 3-factors. The GC–MS analysis of the essential oil was performed for the 17-runs. The optimized extraction of the oil was performed employing numerical optimization and studied for antimicrobial, Minimum Inhibitory Concentration (MIC) and biofilm inhibitory activities. The 3 factors followed rank (plant material amount > water volume > NaCl percent in water), in their magnitude of effect on increasing yield of the oil. Increasing the plant material amount increased the yield of the oil by 6-folds compared to NaCl percent in water. The optimized yield of oil (4 ml) was obtained from extraction criteria (150 g of plant, 750 ml of water and 3.585% (26.85 g) of NaCl). Computational docking was performed to overcome the multi-drug resistant Gram-negative bacilli targeting undecaprenyl pyrophosphate synthase (UPPS). The optimized oil exhibited a promising inhibitory activity against Gram-negative bacteria (K. pneumonia and P. aeruginosa) with significant antibiofilm action (P < 0.05). Moreover, it exerted a synergistic effect when combined with various antibiotics (Cefoxitin, Cloxacillin, Oxacillin and Vancomycin) against MRSA clinical strains.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; El-Ashmawy, Ahmed A. 2
; Kassem, Hanaa A. H. 3 ; Eissa, Ibrahim H. 4 ; Abu-Elghait, Mohammed 5 ; Younis, Nermin A. 1 ; Younis, Inas Y. 3
1 Ahram Canadian University, Pharmacognosy Department, Faculty of Pharmacy, Giza, Egypt (GRID:grid.442461.1) (ISNI:0000 0004 0490 9561)
2 National Research Centre, Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Institute, Giza, Egypt (GRID:grid.419725.c) (ISNI:0000 0001 2151 8157)
3 Cairo University, Pharmacognosy Department, Faculty of Pharmacy, Cairo, Egypt (GRID:grid.7776.1) (ISNI:0000 0004 0639 9286)
4 Al-Azhar University, Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys), Cairo, Egypt (GRID:grid.411303.4) (ISNI:0000 0001 2155 6022)
5 Al-Azhar University, Department of Botany and Microbiology, Faculty of Science, Cairo, Egypt (GRID:grid.411303.4) (ISNI:0000 0001 2155 6022)




